Comparison Chart Legend Biotech Corporation
Equities
LEGN
US52490G1022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.75 USD | -1.57% |
|
-1.16% | -13.75% |
| 03-11 | Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says | MT |
| 03-11 | RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORPORATION | Bio Therapeutic Drugs | -1.57% | -1.16% | -13.75% | -49.60% | -25.98% | 3.47B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition